Related Funds
Funds with similar focus
Fund Name | Location |
Acartha Group | Missouri, St Louis, United States |
Apricot Ventures | Chiyoda, Japan |
Arkansas Development Finance Authority | Arkansas, Little Rock, United States |
Asimov Ventures | New York, New York, United States |
Beijing Ant Cell Tour International Travel Service | Beijing, Beijing, China |
Hasso Plattner Institute | Brandenburg, Germany, Potsdam |
Haxee Ventures | Salt Lake City, United States, Utah |
IDEO | California, Palo Alto, United States |
iStarter | England, London, United Kingdom |
JEKI | Japan, Tokyo |
Jinxin Gongxiao Fund | Beijing, Beijing, China |
Mont Capital | China, Guangdong, Shenzhen |
MVP Capital | Pennsylvania, Radnor, United States |
Rcapital | England, London, United Kingdom |
Reall | Coventry, England, United Kingdom |
Tower Capital Partners | New York, Suffern, United States |
Transcend Fund | - |
Yellowdog | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ArborXR | $12M | 13 Aug 2024 | Norman, Oklahoma, United States | ||
Lumata Health | $5M | 01 Feb 2024 | Edmond, Oklahoma, United States | ||
CorriXR Therapeutics | 16 Jan 2024 | Wilmington, Delaware, United States | |||
Cadenza Bio | $2M | 14 Dec 2023 | - | ||
PatchRx | $8M | 30 Aug 2023 | Tulsa, Oklahoma, United States | ||
Mate Fertility | $5M | 23 May 2023 | Los Angeles, California, United States | ||
Ox | $12M | 25 Apr 2023 | Arkansas, United States | ||
Ox | 23 Mar 2023 | Arkansas, United States | |||
MooveAI | $3M | 16 Mar 2023 | Lafayette, Colorado, United States |
– Recuro Health is a Dallas, TX-based integrated digital health solutions company.
– Company raised $15m in Series A funding.
– The round was led by ARCH Venture Partners, with participation from OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners.
– The new investment will be used to execute the company’s ongoing acquisition and expanded marketing strategy, as well as to further build upon growth since the launch in March 2021.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ArborXR | $12M | 13 Aug 2024 | Norman, Oklahoma, United States | ||
Lumata Health | $5M | 01 Feb 2024 | Edmond, Oklahoma, United States | ||
CorriXR Therapeutics | 16 Jan 2024 | Wilmington, Delaware, United States | |||
Cadenza Bio | $2M | 14 Dec 2023 | - | ||
PatchRx | $8M | 30 Aug 2023 | Tulsa, Oklahoma, United States | ||
Mate Fertility | $5M | 23 May 2023 | Los Angeles, California, United States | ||
Ox | $12M | 25 Apr 2023 | Arkansas, United States | ||
Ox | 23 Mar 2023 | Arkansas, United States | |||
MooveAI | $3M | 16 Mar 2023 | Lafayette, Colorado, United States |